July 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJuly 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceutical contract manufacturing market is growing due to contract manufacturers making significant inves...
April 21, 2026
According to market projections, the radiation-induced dermatitis drug sector is expected to grow from USD 510 million in 2024 to USD 729.2 million by 2034, reflecting a CAGR of 3.64%. The growing need for radiation therapy and the increasing development of biologics bolster market growth. North America led the global market owing to the robust hea...
April 21, 2026
According to forecasts, the global collagen and gelatin market will grow from USD 1.25 billion in 2024 to USD 2.2 billion by 2034, with an expected CAGR of 5.84%. The market is growing due to rising consumer demand for clean-label, protein-rich supplements and their increasing use in food, cosmetics, and biomedical applications. Additionally, the...
April 21, 2026
Based on market forecasts, the global advanced liver cancer market, projected at USD 2.65 billion in 2024, is expected to reach USD 8.2 billion by 2034, growing at a CAGR of 11.94% over the forecast period. Emergence of diverse severe liver issues and rising demand for advanced therapies are encouraging the global market expansion. The highly adv...
April 21, 2026
Based on market forecasts, the pleural biopsy sector will expand from USD 329.03 million in 2024 to USD 594.6 million by 2034, experiencing a CAGR of 6.14%. The pleural biopsy market is expanding due to rising demand for pleural diagnostics as well as increasing use of video-assisted thoracoscopic surgery. North America led the market due to the ...
April 21, 2026
The Market is expanding rapidly as breakthroughs in genetic engineering and precision medicine unlock effective treatments for previously untreatable cancers. Investment in universal CAR-T platforms, combination strategies with checkpoint inhibitors, and a strong clinical pipeline is accelerating innovation and broadening adoption....
April 21, 2026
Research studies indicate that the in vivo CAR-T platform market is experiencing significant growth, driven by the rising demand for CAR-T cell therapies and ongoing technological advancements. North America leads the global market, supported by a strong presence of key industry players and a well-established research infrastructure....
April 21, 2026
Projections indicate that, mice model industry is projected to rise from USD 1.57 billion in 2024 to USD 4.1 billion by 2034, reflecting a CAGR of 10.04% over the next decade. The mice model market is rising strongly due to the growing research in drug development for various diseases. North America is leading the market due to the rising numb...
April 21, 2026
According to market projections, the liquid biopsy tube sector is expected to grow from USD 1.34 billion in 2024 to USD 5.32 billion by 2034, reflecting a CAGR of 14.85%. These specialized tubes offer a revolutionary alternative to traditional biopsy methods by improving patient comfort and enabling real-time disease monitoring....
April 21, 2026
Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North America is leading the market due to the focus on early diagnosis to prevent healthcare complications an...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
